Literature DB >> 20298933

Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction.

Zhi-Qing Zhao1, John D Puskas2, Di Xu2, Ning-Ping Wang3, Mario Mosunjac2, Robert A Guyton2, Jakob Vinten-Johansen2, Robert Matheny4.   

Abstract

OBJECTIVES: This study tested the hypothesis that modulation of angiogenesis and cardiac function by injecting small intestine extracellular matrix emulsion (EMU) into myocardium is associated with recruitment of c-kit cells, myofibroblasts, and macrophages after myocardial infarction.
BACKGROUND: Degradation of native extracellular matrix has been associated with adverse cardiac remodeling after infarction.
METHODS: Sixty-four rats were subjected to 45 min ischemia followed by 3, 7, 21, and 42 days of reperfusion, respectively. Saline or EMU (30 to 50 microl) was injected into the area at risk myocardium after reperfusion. Histological examination was performed by immunohistochemical staining, and cardiac function was analyzed using echocardiography.
RESULTS: The population of c-kit-positive cells in infarcted myocardium with the EMU injection increased significantly relative to the saline control at 7 days of reperfusion. Along with this change, alpha-smooth muscle actin expressing myofibroblasts and macrophages accumulated to a significant extent compared with the saline control. Increased vascular endothelial growth factor protein level and strong immunoreactivity of vascular endothelial growth factor expression were observed. Angiogenesis in the EMU area was significantly enhanced relative to the saline control, evidenced by increased density of alpha-smooth muscle actin positive vessels. Furthermore, echocardiography showed significant improvements in fractional shortening, ejection fraction, and stroke volume in the EMU group. The wall thickness of the infarcted middle anterior septum in the EMU group was significantly increased relative to the saline control.
CONCLUSIONS: We show for the first time that injection of EMU into the infarcted myocardium increases neovascularization and preserves cardiac function, potentially mediated by enhanced recruitment of c-kit-positive cells, myofibroblasts, and macrophages. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20298933     DOI: 10.1016/j.jacc.2009.10.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

Review 1.  Using biomaterials to improve the efficacy of cell therapy following acute myocardial infarction.

Authors:  Jay H Traverse
Journal:  J Cardiovasc Transl Res       Date:  2011-11-17       Impact factor: 4.132

2.  Right ventricular outflow tract repair with a cardiac biologic scaffold.

Authors:  John M Wainwright; Ryotaro Hashizume; Kazuro L Fujimoto; Nathaniel T Remlinger; Colin Pesyna; William R Wagner; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Cells Tissues Organs       Date:  2011-10-24       Impact factor: 2.481

Review 3.  Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.

Authors:  Settimio Pacelli; Sayantani Basu; Jonathan Whitlow; Aparna Chakravarti; Francisca Acosta; Arushi Varshney; Saman Modaresi; Cory Berkland; Arghya Paul
Journal:  Adv Drug Deliv Rev       Date:  2017-07-19       Impact factor: 15.470

4.  A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction.

Authors:  Domenico G Della Rocca; Bradley J Willenberg; Leonardo F Ferreira; Prateek S Wate; John W Petersen; Eileen M Handberg; Tong Zheng; Dennis A Steindler; Naohiro Terada; Christopher D Batich; Barry J Byrne; Carl J Pepine
Journal:  Med Hypotheses       Date:  2012-08-28       Impact factor: 1.538

5.  Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury.

Authors:  Swathi Ravi; Jeffrey M Caves; Adam W Martinez; Jiantao Xiao; Jing Wen; Carolyn A Haller; Michael E Davis; Elliot L Chaikof
Journal:  Biomaterials       Date:  2012-07-21       Impact factor: 12.479

Review 6.  Decellularized Extracellular Matrix Materials for Cardiac Repair and Regeneration.

Authors:  Donald Bejleri; Michael E Davis
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

Review 7.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?

Authors:  Maribella Domenech; Lilliana Polo-Corrales; Jaime E Ramirez-Vick; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2016-07-21       Impact factor: 6.389

8.  Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction.

Authors:  Ke Cheng; Konstantinos Malliaras; Deliang Shen; Eleni Tseliou; Vittoria Ionta; Jeremy Smith; Giselle Galang; Baiming Sun; Christiane Houde; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2012-01-17       Impact factor: 24.094

Review 9.  Biomaterial applications in cardiovascular tissue repair and regeneration.

Authors:  Mai T Lam; Joseph C Wu
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-08

Review 10.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.